381
Views
93
CrossRef citations to date
0
Altmetric
Original Article

Psychiatrie and Pain Characteristics of Prescription Drug Abusers Entering Drug Rehabilitation

(Assistant Professor) (Chief Executive Officer) (Associate Professor) (Associate Member) (Assistant Professor) (Chief Executive Officer) (Associate Professor) (Associate Member) (Assistant Professor) (Chief Executive Officer) (Associate Professor) (Associate Member) (Assistant Professor) (Chief Executive Officer) (Associate Professor) (Associate Member) , , &
Pages 5-13 | Received 04 Oct 2005, Accepted 20 Nov 2005, Published online: 17 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (26)

Joseph B. Oliver, Urvya R. Iyer & Aziz M. Merchant. (2022) The Association of Chronic Opioid Use with Resource Utilization and Outcomes after Emergency General Surgery. Journal of Investigative Surgery 35:2, pages 257-262.
Read now
Pauline Voon, Linwei Wang, Ekaterina Nosova, Kanna Hayashi, Michael John Milloy, Evan Wood & Thomas Kerr. (2020) Greater Pain Severity is Associated with Inability to Access Addiction Treatment Among a Cohort of People Who Use Drugs. Journal of Pain Research 13, pages 2443-2449.
Read now
Joseph V. Pergolizzi$suffix/text()$suffix/text(), Robert Taylor$suffix/text()$suffix/text(), Jo Ann LeQuang & Robert B. Raffa. (2018) What’s holding back abuse-deterrent opioid formulations? Considering 12 U.S. stakeholders. Expert Opinion on Drug Delivery 15:6, pages 567-576.
Read now
Richard N Rosenthal & Viral V Goradia. (2017) Advances in the delivery of buprenorphine for opioid dependence. Drug Design, Development and Therapy 11, pages 2493-2505.
Read now
Tiffani D. Eisenhauer, Mike Matchett, Ralph Heasley, Terri Morton, Krishna Devarakonda, Michael Giuliani, Jim L. Young & Thomas Barrett. (2016) Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets. Drug Development and Industrial Pharmacy 42:1, pages 157-165.
Read now
Maciej Gasior, Mary Bond & Richard Malamut. (2016) Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations. Postgraduate Medicine 128:1, pages 85-96.
Read now
Lynn R. Webster, Michael J. Brennan, Louis M. Kwong, Richard Levandowski & Jeffrey A. Gudin. (2016) Opioid abuse-deterrent strategies: role of clinicians in acute pain management. Postgraduate Medicine 128:1, pages 76-84.
Read now
Wayne Wakeland, Alexandra Nielsen & Peter Geissert. (2015) Dynamic model of nonmedical opioid use trajectories and potential policy interventions. The American Journal of Drug and Alcohol Abuse 41:6, pages 508-518.
Read now
David J. Mastropietro & Hossein Omidian. (2013) Current approaches in tamper-resistant and abuse-deterrent formulations. Drug Development and Industrial Pharmacy 39:5, pages 611-624.
Read now
Jeffrey A. Gudin. (2013) Assessment of Extended-Release Opioid Analgesics for the Treatment of Chronic Pain. Journal of Pain & Palliative Care Pharmacotherapy 27:1, pages 49-61.
Read now
Laura M Lourenço, Michele Matthews & Robert N Jamison. (2013) Abuse-deterrent and tamper-resistant opioids: how valuable are novel formulations in thwarting non-medical use?. Expert Opinion on Drug Delivery 10:2, pages 229-240.
Read now
Kenneth Kirsh, John Peppin & John Coleman. (2012) Characterization of Prescription Opioid Abuse in the United States: Focus on Route of Administration. Journal of Pain & Palliative Care Pharmacotherapy 26:4, pages 348-361.
Read now
Marco Pappagallo & Marta Sokolowska. (2012) The Implications of Tamper–Resistant Formulations for Opioid Rotation. Postgraduate Medicine 124:5, pages 101-109.
Read now
Steven Stanos. (2012) Continuing evolution of opioid use in primary care practice: implications of emerging technologies. Current Medical Research and Opinion 28:9, pages 1505-1516.
Read now
Nathaniel Katz, Richard C. Dart, Elise Bailey, Jeremiah Trudeau, Eric Osgood & Florence Paillard. (2011) Tampering with Prescription Opioids: Nature and Extent of the Problem, Health Consequences, and Solutions. The American Journal of Drug and Alcohol Abuse 37:4, pages 205-217.
Read now
Bill H. McCarberg. (2011) Pain Management in Primary Care: Strategies to Mitigate Opioid Misuse, Abuse, and Diversion. Postgraduate Medicine 123:2, pages 119-130.
Read now
Irma H Benedek, Janet Jobes, Qinfang Xiang & William D Fiske. (2011) Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release. Drug Design, Development and Therapy 5, pages 455-463.
Read now
Roy D. Altman & Howard S. Smith. (2010) Opioid Therapy for Osteoarthritis and Chronic Low Back Pain. Postgraduate Medicine 122:6, pages 87-97.
Read now
JosephD. Markowitz, ElieM. Francis & Cheryl Gonzales-Nolas. (2010) Managing Acute and Chronic Pain in a Substance Abuse Treatment Program for the Addicted Individual Early in Recovery: A Current Controversy. Journal of Psychoactive Drugs 42:2, pages 193-198.
Read now
Betty D. Morgan & Donna M. White. (2009) Managing Pain in Patients with Co-Occurring Addictive Disorders. Journal of Addictions Nursing 20:1, pages 41-48.
Read now
MarthaJ. Wunsch, Kent Nakamoto, Anil Goswami & SidneyH. Schnoll. (2007) Prescription Drug Abuse Among Prisoners in Rural Southwestern Virginia. Journal of Addictive Diseases 26:4, pages 15-22.
Read now
Meredith Y. Smith, J. David Haddox & Michael E. Di Maino. (2007) Correlates of Nonmedical Use of Hydromorphone and Hydrocodone. Journal of Pain & Palliative Care Pharmacotherapy 21:3, pages 5-17.
Read now

Articles from other publishers (67)

Chinwe Nwaneshiudu, Xiao-Yu Shi, Peyman Sahbaie & J David Clark. (2023) Functional bias of morphine and oliceridine under conditions of minor injury. Molecular Pain 17, pages 174480692098844.
Crossref
Robert G. Carlson, Raminta Daniulaityte, Sydney M. Silverstein, Ramzi W. Nahhas & Silvia S. Martins. (2020) Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?. International Journal of Drug Policy 79, pages 102722.
Crossref
Richard L. Rauck. (2019) Mitigation of IV Abuse Through the Use of Abuse‐Deterrent Opioid Formulations: An Overview of Current Technologies . Pain Practice 19:4, pages 443-454.
Crossref
Aaron J. Salwan, Nicholas E. Hagemeier & Sam Harirforoosh. (2018) Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?. Clinical Drug Investigation 38:7, pages 573-577.
Crossref
Ronald S. Litman, Olivia H. Pagán & Theodore J. Cicero. (2018) Abuse-deterrent Opioid Formulations. Anesthesiology 128:5, pages 1015-1026.
Crossref
Jennifer Hah, Sean C. Mackey, Peter Schmidt, Rebecca McCue, Keith Humphreys, Jodie Trafton, Bradley Efron, Debra Clay, Yasamin Sharifzadeh, Gabriela Ruchelli, Stuart Goodman, James Huddleston, William J. Maloney, Frederick M. Dirbas, Joseph Shrager, John G. Costouros, Catherine Curtin & Ian Carroll. (2018) Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort. JAMA Surgery 153:4, pages 303.
Crossref
Jennifer M. HahBrian T. BatemanJohn RatliffCatherine CurtinEric Sun. (2017) Chronic Opioid Use After Surgery: Implications for Perioperative Management in the Face of the Opioid Epidemic. Anesthesia & Analgesia 125:5, pages 1733-1740.
Crossref
Jerry JonesJr.Jr., Warren Southerland & Blas Catalani. (2017) The Importance of Optimizing Acute Pain in the Orthopedic Trauma Patient. Orthopedic Clinics of North America 48:4, pages 445-465.
Crossref
Andrew A. Monte, Diane P. Calello, Roy R. Gerona, Eike Hamad, Sharan L. Campleman, Jeffery Brent, Paul Wax & Robert G. Carlson. (2017) Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study. Journal of Medical Toxicology 13:2, pages 146-152.
Crossref
Alix Zuleta-Alarcón, John C. Coffman, Suren Soghomonyan, Thomas J. Papadimos, Sergio D. Bergese & Kenneth R. Moran. (2016) Non-opioid anesthetic drug abuse among anesthesia care providers: a narrative reviewL’abus de médicaments anesthésiques non opioïdes parmi le personnel d’anesthésie: un compte rendu narratif. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 64:2, pages 169-184.
Crossref
Jennifer Hah. (2016) Taking adolescent prescription opioid use in context: risk stratification in early mid-life based on medical and nonmedical use. Pain 157:10, pages 2143-2144.
Crossref
Mark R. Jones, Martin J. Carney, Rachel J. Kaye, Amit Prabhakar & Alan D. Kaye. (2016) Drug Formulation Advances in Extended-Release Medications for Pain Control. Current Pain and Headache Reports 20:6.
Crossref
Juliana Tournebize, Valérie Gibaja, Amandine Muszczak & Jean-Pierre Kahn. (2016) Are Physicians Safely Prescribing Opioids for Chronic Noncancer Pain? A Systematic Review of Current Evidence. Pain Practice 16:3, pages 370-383.
Crossref
Robert G. Carlson, Ramzi W. Nahhas, Silvia S. Martins & Raminta Daniulaityte. (2016) Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study. Drug and Alcohol Dependence 160, pages 127-134.
Crossref
Amy Peacock, Louisa Degenhardt, Antonia Hordern, Briony Larance, Elena Cama, Nancy White, Ivana Kihas & Raimondo Bruno. (2015) Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulation. International Journal of Drug Policy 26:12, pages 1265-1272.
Crossref
Amy Peacock, Louisa Degenhardt, Briony Larance, Elena Cama, Nicholas Lintzeris, Robert Ali & Raimondo Bruno. (2015) A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone. Pharmacoepidemiology and Drug Safety 24:12, pages 1321-1333.
Crossref
Patrick Tighe, Chester C. BuckenmaierIIIIII, Andre P. Boezaart, Daniel B. Carr, Laura L. Clark, Andrew A. Herring, Michael Kent, Sean Mackey, Edward R. Mariano, Rosemary C. Polomano & Gary M. Reisfield. (2015) Acute Pain Medicine in the United States: A Status Report. Pain Medicine 16:9, pages 1806-1826.
Crossref
Erin Stevenson & Jennifer Cole. (2015) Associations between chronic non‐cancer pain and medication assisted treatment outcomes for opiate addiction. The American Journal on Addictions 24:2, pages 138-143.
Crossref
Nelson E. Sessler, Jerod M. Downing, Hrishikesh Kale, Howard D. Chilcoat, Todd F. Baumgartner & Paul M. Coplan. (2014) Reductions in reported deaths following the introduction of extended‐release oxycodone (OxyContin) with an abuse‐deterrent formulation. Pharmacoepidemiology and Drug Safety 23:12, pages 1238-1246.
Crossref
Jenna L. McCauley, Mary Ashley Mercer, Kelly S. Barth, Kathleen T. Brady & Sudie E. Back. (2014) Pain management perceptions among prescription opioid dependent individuals. Drug and Alcohol Dependence 142, pages 354-358.
Crossref
Jennifer M. Hah, Sean Mackey, Peter L. Barelka, Charlie K. M. Wang, Bing M. Wang, Matthew J. Gillespie, Rebecca McCue, Jarred W. Younger, Jodie Trafton, Keith Humphreys, Stuart B. Goodman, Fredrick M. Dirbas, Peter C. Schmidt & Ian R. Carroll. (2014) Self-Loathing Aspects of Depression Reduce Postoperative Opioid Cessation Rate. Pain Medicine 15:6, pages 954-964.
Crossref
Louis Alexander, Richard O. Mannion, Brianne Weingarten, Richard J. Fanelli & Gary L. Stiles. (2014) Development and impact of prescription opioid abuse deterrent formulation technologies. Drug and Alcohol Dependence 138, pages 1-6.
Crossref
Mark T. Leibowitz, Cynthia A. Zamora, Albert W. Brzeczko & Jeffrey G. Stark. (2014) A Single-Dose, 3-Way Crossover Pharmacokinetic Comparison Between Immediate-Release Oxycodone Hydrochloride With Aversion Technology (IRO-A, Oxecta), IRO-A With Niacin, and Oxycodone Hydrochloride (Roxicodone) in Healthy Adults Under Fasting Conditions. American Journal of Therapeutics 21:2, pages 99-105.
Crossref
Elliot M. Goldner, Anna Lusted, Michael Roerecke, Jürgen Rehm & Benedikt Fischer. (2014) Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: Systematic review and meta-analyses. Addictive Behaviors 39:3, pages 520-531.
Crossref
Sindhuri Maddineni, Sunil Kumar Battu, Joe Morott, Majumdar Soumyajit & Michael A Repka. (2014) Formulation optimization of hot-melt extruded abuse deterrent pellet dosage form utilizing design of experiments. Journal of Pharmacy and Pharmacology 66:2, pages 309-322.
Crossref
Robert G. Carlson, Ramzi W. Nahhas, Raminta Daniulaityte, Silvia S. Martins, Linna Li & Russel Falck. (2014) Latent class analysis of non-opioid dependent illegal pharmaceutical opioid users in Ohio. Drug and Alcohol Dependence 134, pages 259-266.
Crossref
Paul M. Coplan, Hrishikesh Kale, Lauren Sandstrom, Craig Landau & Howard D. Chilcoat. (2013) Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended‐release oxycodone with abuse‐deterrent characteristics. Pharmacoepidemiology and Drug Safety 22:12, pages 1274-1282.
Crossref
Sarah Cox. (2013) The issues around opioid prescribing in HIV-related pain. Pain Management 3:5, pages 377-385.
Crossref
William E. McAuliffe, Silvia Minozzi, Laura Amato & Marina Davoli. (2013) A critique of Minozzi et al .'s pain relief and dependence systematic review, and authors' response . Addiction 108:6, pages 1162-1171.
Crossref
M.K. Romach, K.A. Schoedel & E.M. Sellers. (2013) Update on tamper-resistant drug formulations. Drug and Alcohol Dependence 130:1-3, pages 13-23.
Crossref
Daniel F. Gros, Melissa E. Milanak, Kathleen T. Brady & Sudie E. Back. (2013) Frequency and Severity of Comorbid Mood and Anxiety Disorders in Prescription Opioid Dependence. The American Journal on Addictions 22:3, pages 261-265.
Crossref
Tami L. Mark, Joan Dilonardo, Rita Vandivort & Kay Miller. (2013) Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine. Journal of Substance Abuse Treatment 44:5, pages 481-487.
Crossref
Stephen F. Butler, Theresa A. Cassidy, Howard Chilcoat, Ryan A. Black, Craig Landau, Simon H. Budman & Paul M. Coplan. (2013) Abuse Rates and Routes of Administration of Reformulated Extended-Release Oxycodone: Initial Findings From a Sentinel Surveillance Sample of Individuals Assessed for Substance Abuse Treatment. The Journal of Pain 14:4, pages 351-358.
Crossref
Lara Dhingra, Carmen Masson, David C. Perlman, Randy M. Seewald, Judith Katz, Courtney McKnight, Peter Homel, Emily Wald, Ashly E. Jordan, Christopher Young & Russell K. Portenoy. (2013) Epidemiology of pain among outpatients in methadone maintenance treatment programs. Drug and Alcohol Dependence 128:1-2, pages 161-165.
Crossref
R. Scharnagel, U. Kaiser, A. Schütze, R. Heineck, G. Gossrau & R. Sabatowski. (2013) Chronische nichttumorbedingte SchmerzenChronic non-cancer-related pain. Der Schmerz 27:1, pages 7-19.
Crossref
Simon Holliday, Parker Magin, Janet Dunbabin, Christopher Oldmeadow, Julie-Marie Henry, Nicholas Lintzeris, John Attia, Susan Goode & Adrian Dunlop. (2013) An Evaluation of the Prescription of Opioids for Chronic Nonmalignant Pain by Australian General Practitioners. Pain Medicine 14:1, pages 62-74.
Crossref
Elizabeth C.H. Eyler. (2013) Chronic and Acute Pain and Pain Management for Patients in Methadone Maintenance Treatment. The American Journal on Addictions 22:1, pages 75-83.
Crossref
Tammi Schaeffer. (2012) Abuse-Deterrent Formulations, an Evolving Technology Against the Abuse and Misuse of Opioid Analgesics. Journal of Medical Toxicology 8:4, pages 400-407.
Crossref
Ian Carroll, Peter Barelka, Charlie Kiat Meng Wang, Bing Mei Wang, Matthew John Gillespie, Rebecca McCue, Jarred W. Younger, Jodie Trafton, Keith Humphreys, Stuart B. Goodman, Fredrick Dirbas, Richard I. Whyte, Jessica S. Donington, Walter B. Cannon & Sean Charles Mackey. (2012) A Pilot Cohort Study of the Determinants of Longitudinal Opioid Use After Surgery. Anesthesia & Analgesia 115:3, pages 694-702.
Crossref
Steven P. Stanos, Patricia Bruckenthal & Robert L. Barkin. (2012) Strategies to Reduce the Tampering and Subsequent Abuse of Long-acting Opioids: Potential Risks and Benefits of Formulations With Physical or Pharmacologic Deterrents to Tampering. Mayo Clinic Proceedings 87:7, pages 683-694.
Crossref
Lynn R. Webster, Brad Bath, Robert A. Medve, Tonya Marmon & Gregory J. Stoddard. (2012) Randomized, Double-Blind, Placebo-Controlled Study of the Abuse Potential of Different Formulations of Oral Oxycodone. Pain Medicine 13:6, pages 790-801.
Crossref
Michael Saulino, Adam Schreiber & Thomas Watanabe. (2012) The Appropriateness of Long-term Opioids to Treat Chronic Back Pain. PM&R 4:4, pages 304-311.
Crossref
William D. Fiske, Janet Jobes, Qinfang Xiang, Sou-Chan Chang & Irma H. Benedek. (2012) The Effects of Ethanol on the Bioavailability of Oxymorphone Extended-Release Tablets and Oxymorphone Crush-Resistant Extended-Release Tablets. The Journal of Pain 13:1, pages 90-99.
Crossref
Erica Amari, Jürgen Rehm, Elliot Goldner & Benedikt Fischer. (2011) Nonmedical Prescription Opioid Use and Mental Health and Pain Comorbidities: A Narrative Review. The Canadian Journal of Psychiatry 56:8, pages 495-502.
Crossref
Sudie E. Back, Katie M. Lawson, Lauren M. Singleton & Kathleen T. Brady. (2011) Characteristics and correlates of men and women with prescription opioid dependence. Addictive Behaviors 36:8, pages 829-834.
Crossref
Steven A. Galati & Michael R. Clark. 2011. Essentials of Pain Medicine. Essentials of Pain Medicine 184 192 .
April M Young, Jennifer R Havens & Carl G Leukefeld. (2010) Route of administration for illicit prescription opioids: a comparison of rural and urban drug users. Harm Reduction Journal 7:1.
Crossref
Benedikt Fischer, Meagan Bibby & Martin Bouchard. (2010) The Global Diversion of Pharmaceutical Drugs
Non‐medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures. Addiction 105:12, pages 2062-2070.
Crossref
Michael R. Clark & Steven A. Galati. (2012) Opioids and psychological issues: A practical, patient‐centered approach to a risk evaluation and mitigation strategy. European Journal of Pain Supplements 4:S4, pages 261-267.
Crossref
Robert J. DeFalco, Michael Erlichman, Sharang Tickoo & Steven D. Passik. (2010) Substance Abuse Issues in Oral and Maxillofacial Practice. Oral and Maxillofacial Surgery Clinics of North America 22:4, pages 527-535.
Crossref
Jeff Gudin. 2010. The Essence of Analgesia and Analgesics. The Essence of Analgesia and Analgesics 90 93 .
Marta C. Canfield, Craig E. Keller, Lynne M. Frydrych, Lisham Ashrafioun, Christopher H. Purdy & Richard D. Blondell. (2010) Prescription Opioid Use Among Patients Seeking Treatment for Opioid Dependence. Journal of Addiction Medicine 4:2, pages 108-113.
Crossref
Henry J. Carson & Bradley L. Feickert. (2009) Identification at autopsy of pulverized pills in lungs of a first-time methadone user. Journal of Forensic and Legal Medicine 16:8, pages 494-496.
Crossref
Michael R. Clark. (2009) Psychiatry and chronic pain: Examining the interface and designing a structure for a patient-center approach to treatment. European Journal of Pain Supplements 3:S2, pages 95-100.
Crossref
Miroslav "Misha" Backonja. (2009) THE ROLE OF OPIOID THERAPY IN THE TREATMENT OF NEUROPATHIC PAIN. CONTINUUM: Lifelong Learning in Neurology 15, pages 84-100.
Crossref
R. Daniulaityte, R.S. Falck, J. Wang & R.G. Carlson. (2009) Illicit use of pharmaceutical opioids among young polydrug users in Ohio. Addictive Behaviors 34:8, pages 649-653.
Crossref
Steven D. Passik. (2009) Issues in Long-term Opioid Therapy: Unmet Needs, Risks, and Solutions. Mayo Clinic Proceedings 84:7, pages 593-601.
Crossref
Steven D. Passik. (2009) Issues in Long-term Opioid Therapy: Unmet Needs, Risks, and Solutions. Mayo Clinic Proceedings 84:7, pages 593-601.
Crossref
Michael R. Clark. (2009) Psychiatric issues in chronic pain. Current Psychiatry Reports 11:3, pages 243-250.
Crossref
Steven P. Stanos, David A. Fishbain & Scott M. Fishman. (2009) Pain Management with Opioid Analgesics. American Journal of Physical Medicine & Rehabilitation 88:3, pages S69-S99.
Crossref
Steven D. Passik & Kenneth L. Kirsh. 2009. Current Therapy in Pain. Current Therapy in Pain 392 395 .
George A Kenna & David C Lewis. (2008) Risk factors for alcohol and other drug use by healthcare professionals. Substance Abuse Treatment, Prevention, and Policy 3:1.
Crossref
Ryan M. Caldeiro, Carol A. Malte, Donald A. Calsyn, John S. Baer, Paul Nichol, Daniel R. Kivlahan & Andrew J. Saxon. (2008) The association of persistent pain with out-patient addiction treatment outcomes and service utilization. Addiction 103:12, pages 1996-2005.
Crossref
Kelly E. Dunn, Stacey C. Sigmon, Mark R. McGee, Sarah H. Heil & Stephen T. Higgins. (2008) Evaluation of ongoing oxycodone abuse among methadone-maintained patients. Journal of Substance Abuse Treatment 35:4, pages 451-456.
Crossref
Barth L. Wilsey, Scott M. Fishman, Alexander Tsodikov, Christine Ogden, Ingela Symreng & Amy Ernst. (2008) Psychological Comorbidities Predicting Prescription Opioid Abuse among Patients in Chronic Pain Presenting to the Emergency Department. Pain Medicine 9:8, pages 1107-1117.
Crossref
Michael R Clark, Kenneth B Stoller & Robert K Brooner. (2008) Assessment and Management of Chronic Pain in Individuals Seeking Treatment for Opioid Dependence Disorder. The Canadian Journal of Psychiatry 53:8, pages 496-508.
Crossref
Steven D. Passik & Kenneth L. Kirsh. (2008) Forget the Recipes: Let's Talk Data. Pain Medicine 9:2, pages 261-265.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.